United Natural Foods
UNFI
43.59
-0.70
-1.58%
United Natural Foods
US · UNFI
#2573 by market cap
Listed 1970
43.59
-0.70
-1.58%
Live - 5344 symbols - heartbeat 568s ago
· 2026-10-08 07:07
Pre-market
43.42
-0.39%
After-hours
43.59
0.00%
- Market cap
- 2.63B
- P/E (TTM)i
- 32.53
- P/Bi
- 1.62
- EPSi
- 1.34
- Div yieldi
- 0.00%
- 52W posi
- 49%
Reader sentiment
Are you bullish or bearish on UNFI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.99% YoY
Margins
- Gross margin
- 13.47%
- Operating margin
- 0.93%
- Net margin
- 0.27%
Key ratios & quality
- Enterprise valuei
- 4.30B
- PEG ratioi
- 0.63
- Altman Z-Scorei
- 5.14
PEG uses trailing P/E against the 3-year net income growth rate (51.83%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.34B | 26.56B | 26.95B | 28.93B | 30.27B | 30.98B | 31.78B | 31.15B |
| Gross profit | 3.22B | 3.89B | 3.94B | 4.18B | 4.13B | 4.20B | 4.22B | 4.20B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 244.00M | 337.00M | 346.00M | 357.00M | 158.00M | 101.00M | 105.00M | 290.00M |
| Pretax profit | -341.00M | -342.00M | 183.00M | 310.00M | 7.00M | -137.00M | -154.00M | 102.00M |
| Tax | -59.00M | -91.00M | 34.00M | 56.00M | -23.00M | -27.00M | -39.00M | 18.00M |
| Net profit | -285.00M | -269.00M | 155.00M | 254.00M | 30.00M | -110.00M | -115.00M | 84.00M |
| Basic EPS | -6 | -5 | 3 | 4 | 0 | -2 | -2 | 1 |
| Diluted EPS | -5.56 | -5.10 | 2.48 | 4.07 | 0.40 | -1.89 | -1.95 | 1.34 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 8.06B | 7.70B | 7.84B | 7.95B | 7.72B | 7.64B |
| Gross profit | 1.08B | 1.03B | 1.05B | 1.05B | 1.05B | 1.05B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 57.00M | -16.00M | 55.00M | 74.00M | 95.00M | 66.00M |
| Pretax profit | -16.00M | -109.00M | -9.00M | 23.00M | 42.00M | 46.00M |
| Tax | -9.00M | -23.00M | -5.00M | 3.00M | 9.00M | 11.00M |
| Net profit | -7.00M | -86.00M | -4.00M | 20.00M | 33.00M | 35.00M |
| Basic EPS | 0 | -1 | 0 | 0 | 1 | 1 |
| Diluted EPS | -0.12 | -1.43 | -0.06 | 0.31 | 0.52 | 0.57 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.56B | 3.71B | 3.55B | 3.80B | 3.46B | 3.40B | 3.42B | 3.14B |
| Cash & ST investments | 44.47M | 47.00M | 41.00M | 44.00M | 37.00M | 40.00M | 44.00M | 37.00M |
| Inventory | 2.19B | 2.28B | 2.25B | 2.36B | 2.29B | 2.18B | 2.10B | 1.95B |
| Total assets | 7.17B | 7.59B | 7.53B | 7.63B | 7.39B | 7.53B | 7.60B | 7.11B |
| Total current liabilities | 2.11B | 2.37B | 2.49B | 2.42B | 2.41B | 2.37B | 2.60B | 2.44B |
| Short-term debt | 112.10M | 214.00M | 255.00M | 183.00M | 198.00M | 192.00M | 181.00M | 148.00M |
| Long-term debt | 2.82B | 2.43B | 2.18B | 2.11B | 1.96B | 2.08B | 1.86B | 1.56B |
| Total liabilities | 5,670,030,000.00 | 6,445,000,000.00 | 6,011,000,000.00 | 5,836,000,000.00 | 5,650,000,000.00 | 5,887,000,000.00 | 6,041,000,000.00 | 5,487,000,000.00 |
| Total equity | 1.50B | 1.14B | 1.51B | 1.79B | 1.74B | 1.64B | 1.55B | 1.62B |
| Retained earnings | 1.11B | 838.00M | 978.00M | 1.23B | 1.25B | 1.14B | 1.02B | 1.10B |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 3.43B | 3.42B | 3.50B | 3.25B | 3.24B | 3.14B |
| Cash & ST investments | 52.00M | 44.00M | 38.00M | 52.00M | 43.00M | 37.00M |
| Inventory | 2.19B | 2.10B | 2.24B | 1.99B | 1.99B | 1.95B |
| Total assets | 7.62B | 7.60B | 7.56B | 7.25B | 7.19B | 7.11B |
| Total current liabilities | 2.43B | 2.60B | 2.53B | 2.44B | 2.44B | 2.44B |
| Short-term debt | 184.00M | 181.00M | 157.00M | 157.00M | 172.00M | 148.00M |
| Long-term debt | 1.96B | 1.86B | 1.92B | 1.71B | 1.66B | 1.56B |
| Total liabilities | 5,993,000,000.00 | 6,041,000,000.00 | 6,013,000,000.00 | 5,693,000,000.00 | 5,588,000,000.00 | 5,487,000,000.00 |
| Total equity | 1.62B | 1.55B | 1.55B | 1.55B | 1.60B | 1.62B |
| Retained earnings | 1.11B | 1.02B | 1.02B | 1.04B | 1.07B | 1.10B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 285.00M | 457.00M | 614.00M | 331.00M | 624.00M | 253.00M | 470.00M | 540.00M |
| Depreciation & amortization | 248.00M | 282.00M | 285.00M | 285.00M | 304.00M | 319.00M | 321.00M | 303.00M |
| Free cash flow | 57.00M | 284.00M | 304.00M | 80.00M | 301.00M | -92.00M | 239.00M | 323.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 24.00M | 14.00M | 1.00M | 8.00M | -62.00M | 0 | 0 | -50.00M |
| Ending cash balance | 45.00M | 47.00M | 41.00M | 44.00M | 37.00M | 40.00M | 44.00M | 37.00M |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 173.00M | 160.00M | -38.00M | 283.00M | 98.00M | 197.00M |
| Depreciation & amortization | 81.00M | 79.00M | 77.00M | 74.00M | 74.00M | 78.00M |
| Free cash flow | 119.00M | 86.00M | -54.00M | 243.00M | 54.00M | 80.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -4.00M | -21.00M |
| Ending cash balance | 52.00M | 44.00M | 38.00M | 52.00M | 43.00M | 37.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -16.97 | -20.62 | 11.20 | 15.00 | 1.36 | -6.62 | -7.39 | 5.30 |
| ROA %i | -5.62 | -3.71 | 1.97 | 3.27 | 0.32 | -1.50 | -1.56 | 1.14 |
| ROIC %i | -4.56 | -2.84 | 5.96 | 7.30 | 2.38 | 0.06 | -0.32 | 3.75 |
| 5-year avg ROE %i | 3.92 | -2.33 | -1.82 | -0.45 | -2.02 | 0.06 | 2.71 | 1.53 |
| EBIT margin %i | -1.21 | -0.63 | 1.33 | 1.59 | 0.46 | 0.03 | -0.05 | 0.71 |
| FCF / sales %i | 0.36 | 1.07 | 1.13 | 0.28 | 0.99 | -- | 0.75 | 1.04 |
| Current ratioi | 1.69 | 1.56 | 1.43 | 1.57 | 1.44 | 1.44 | 1.32 | 1.29 |
| Quick ratioi | 0.53 | 0.49 | 0.46 | 0.52 | 0.39 | 0.42 | 0.44 | 0.39 |
| Debt / assetsi | 42.36 | 48.21 | 45.54 | 44.34 | 44.16 | 47.13 | 45.44 | 42.69 |
| LT debt / equityi | 194.24 | 300.79 | 209.37 | 178.62 | 175.96 | 204.51 | 210.83 | 178.10 |
| Interest coveragei | -1.48 | -0.93 | 2.05 | 3.08 | 1.05 | 0.06 | -0.11 | 1.86 |
| Revenue CAGR (3Y) %i | 38.17 | 42.01 | 38.13 | 8.99 | 4.46 | 4.75 | 3.19 | 0.96 |
| Net income CAGR (3Y) %i | -- | -- | -2.90 | -- | -- | -- | -- | 51.83 |
| FCF CAGR (3Y) %i | -39.33 | 9.35 | 67.72 | 11.96 | 1.96 | -- | 44.02 | 2.38 |
| Line item | 2025-05 | 2025-08 | 2025-10 | 2026-01 | 2026-05 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -4.11 | -7.39 | -6.37 | -4.91 | -2.36 | 5.30 |
| ROA %i | -0.89 | -1.56 | -1.30 | -1.04 | -0.51 | 1.14 |
| ROIC %i | 0.72 | -0.32 | -0.11 | 0.21 | 0.95 | 3.75 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.18 | -0.05 | -0.01 | 0.06 | 0.23 | 0.71 |
| FCF / sales %i | 0.69 | 0.75 | 1.08 | 1.25 | 1.05 | 1.04 |
| Current ratioi | 1.41 | 1.32 | 1.38 | 1.33 | 1.33 | 1.29 |
| Quick ratioi | 0.43 | 0.44 | 0.42 | 0.43 | 0.42 | 0.39 |
| Debt / assetsi | 47.03 | 45.44 | 45.88 | 44.67 | 43.87 | 42.69 |
| LT debt / equityi | 209.11 | 210.83 | 214.09 | 198.52 | 186.55 | 178.10 |
| Interest coveragei | 0.39 | -0.11 | -0.02 | 0.15 | 0.58 | 1.86 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Natural is the largest reported line at 54.99% of revenue, across 4 reported segments.
- Conventional follows at 41.65%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Natural54.99%
Conventional41.65%
Retail6.92%
Region
United States and Canada100.00%
Quote time 2026-10-08 07:07:43 · For reference only, not investment advice and not tailored to your situation.